Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

< b > Conditions < /b > :   Hormone-Resistant Prostate Cancer;   Stage IV Prostate Adenocarcinoma < br/ > < b > Interventions < /b > :   Drug: Cabazitaxel;   Drug: Prednisone < br/ > < b > Sponsors < /b > :   University of California, Davis;   Sanofi < br/ > < b > Not yet recruiting < /b > - verified July 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials